In patients with type 2 diabetes (T2D), the risk of major adverse cardiovascular events (MACEs) was lowest among patients ...

New York has confirmed the first locally transmitted chikungunya infection in the United States since 2019. 2. Climate shifts ...

Day and colleagues randomized sonographers to scan pregnant participants with AI assistance or the standard method for ...

At one month, ticagrelor was not superior to twice-daily clopidogrel in reducing major adverse cardiovascular events (MACEs) ...

In this surveillance study, the incidence rates of several cancers increased among both younger and older adults in many of ...

In this cohort of older adults, traumatic brain injury (TBI) in later life was associated with an increased incidence of ...

In this analysis of target trial emulations, at least one dose of the recombinant zoster vaccine was effective in older ...

Among patients with symptomatic chronic heart failure already on guideline-directed medical therapy (GDMT), digitoxin lowered ...

In this randomized clinical trial, the use of a smartphone self-help app was associated with increased self-esteem and ...

Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes 1. In patients with type 2 ...

The FDA has cleared the first Alzheimer’s blood test for community use, marking a pivotal step toward earlier and less ...

In this randomized controlled trial, a multidomain rehabilitation program significantly reduced cardiovascular death and ...